Epstein Secrets

in/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 ABT 61.29 148.000 9,070.92 7,308.74 1,762.18 301.92 3.33% ANALOG DEVICES INC 032654-10-5 ADI 40.40 176.000 7,110.40 6,011.39 1,099.01 211.20 2.97% AUTOMATIC DATA PROCESSING INC 053015-10.3 ADP 55.19 150.000 8278.5

GHISLAINE MAXWELL- OAP FDG ACC For the Period 3/1/12•1. Equity Summary Asset Categories US Large Cap Eguky Beginning Ending Change Current Market Value Market Value In Value Allocation 163,689.55 167,788.39 4,098.84 96% Market Value/Cost Curr

Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 ABT 62.06 148.000 9,184.88 7,308.74 1,876.14 301.92 75.48 3.29% ANALOG DEVICES INC 38.98 206.000 8,029.88 7,138.40 891.48 247.20 3.08% 032854-10-5 ADI JP Morgan Page 4 of 14 Confidential Treatment Requested by JPMorgan C

GHISLAINE MAXWELL- OAP FDG ACCT For the Period 4/1/12 to 4/30/12 Equity Summary Asset Categories US Large Cap Eguky 167.78829 168.660.80 872.41 97% Market Value/Cost Current Penod Value Market Value 168,860.80 Tax Cost 147,070.30 Unrealized Gain/Loss 2

97% Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost GaiNLoss Accrued Div. Yield US Large Cap Eq ti it, ANALOG DEVICES INC 032654-10-5 AEU 46.49 1,262.000 58,670.38 52,767.21 5,903.17 1,716.32 2.93% AUTOMATIC DATA PROCESSING INC 053015-10-3 ADP 85.03 917.000 5

GHISLAINE MAXWELL- OAP FDG ACCT. A45685004 For the Period 3/1/13 to 3/31/13 Equity Summary Asset Categories US Large Cap Eguky Beginning Ending Change Current Market Value Market Value In Value Allocation 1,183,004.22 1,251 732 04 Market Value/Cost Current Penod